Skip to main content

Day: July 1, 2024

Skye Bioscience Added to Russell 2000® and Russell 3000® Indexes

SAN DIEGO, July 01, 2024 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, today announced the Company has been included in the Russell 2000® Index and the broad-market Russell 3000® Index, effective at the U.S. market open on July 1, 2024, as part of the annual reconstitution of the Russell stock indexes. “We are pleased to be included in the Russell indexes, a widely recognized benchmark for small-cap stocks, which is a testament to Skye’s recent accomplishments,” said Kaitlyn Arsenault, the CFO of Skye. “We believe inclusion in these indexes will expand our visibility to the investment community as we continue to build momentum with...

Continue reading

Bridger Aerospace Announces Changes to its Management Team

BELGRADE, Mont., July 01, 2024 (GLOBE NEWSWIRE) — Bridger Aerospace Group Holdings, Inc. (“Bridger”, “the Company” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation’s largest aerial firefighting companies, today announced changes to its management team and Board of Directors (“Board”), including the resignation of the Company’s Chief Executive Officer and Director, Timothy P. Sheehy, who is running for the U.S. Senate in the State of Montana.  As a result, the Board of Directors has named Sam Davis, current Chief of Staff, as interim CEO and Jeffrey Kelter as Executive Chairman.  “The leadership team at Bridger Aerospace, supported by our experienced board, will continue to excel at its core mission; saving lives and protecting property. This exceptional team deserves a fully focused CEO during its busy fire season....

Continue reading

RYVYL Increases Focus on Licensing and Aligns U.S. Operations by Business Unit

-Fintech veteran Christian Murray, who will lead RYVYL’s licensing strategy, expands role from VP of Revenue to newly created position of Managing Director, Northeast Merchant Systems – SAN DIEGO, CA, July 01, 2024 (GLOBE NEWSWIRE) — RYVYL Inc. (NASDAQ: RVYL) (“RYVYL” or the “Company”), a leading innovator of payment transaction solutions leveraging proprietary blockchain ledger and electronic payment technology for diverse international markets, has aligned its U.S. operations to increase its focus on diversifying into new vertical markets within its Northeast Merchant Systems (NEMS) business unit. In addition to leading RYVYLs licensing strategy, Christian Murray, Vice President of Revenue, has been promoted to a newly created position of Managing Director of NEMS effective July 15, 2024. “RYVYL has developed...

Continue reading

Sandy Spring Bancorp, Inc. to Webcast Second Quarter Earnings Conference Call on July 23, 2024

OLNEY, Md., July 01, 2024 (GLOBE NEWSWIRE) — Sandy Spring Bancorp, Inc. (Nasdaq: SASR) will announce its second quarter earnings on Tuesday, July 23, 2024. The company will hold a conference call that day at 2:00 p.m. (ET) to discuss results and answer questions. The conference call will be webcast live through the Sandy Spring Bank website.  Those who wish to participate in order to ask questions may do so by calling 1- 833-470-1428; please use Access Code: 340278. Those who wish to listen to the call should go to the Investor Relations page of www.sandyspringbank.com and log on 10 minutes ahead of the scheduled start of the call. An internet-based replay will be available on the Investor Relations page of the website until August 6, 2024. A telephone voice replay will also be available during that same time period at 1-866-813-9403....

Continue reading

Complete Solaria Eliminates $67.6 Million of Private Equity Debt

LEHI, Utah, July 01, 2024 (GLOBE NEWSWIRE) — Complete Solaria, Inc. (“Complete Solaria” or the “Company”) (Nasdaq: CSLR), a leading solar technology, services, and installation company, today announced that it had cancelled $67.6 million in debt from its balance sheet and been released from its obligations under that debt by its two private equity (PE) providers, Carlyle and Kline Hill Partners. On May 15, 2024, the Company announced that it had signed an agreement with Carlyle to set aside all of its financial claims in return for $10 million in cash. Today, we announce an equivalent deal with Kline Hill Partners for $8 million. On June 17, 2024, the Company announced that T.J. Rodgers had funded the $10 million payment to Carlyle by purchasing a convertible debenture security from the Company through Cantor Fitzgerald &...

Continue reading

Green Thumb Industries to Hold Second Quarter 2024 Earnings Conference Call on August 5, 2024

CHICAGO and VANCOUVER, British Columbia, July 01, 2024 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced it will release second quarter 2024 financial results after the market closes on Monday, August 5, 2024. A conference call and audio webcast will also be held on Monday, August 5, 2024, at 5:00 p.m. Eastern Time/4:00 p.m. Central Time to discuss the results and answer any questions.Live conference call: 844-883-3895 (Toll-Free) and 412-317-5797 (International) Live and archived webcast: https://investors.gtigrows.comParticipants may pre-register for the live conference call any time prior to the start of the call by navigating to https://dpregister.com/sreg/10190210/fce7794bc4...

Continue reading

Brown & Brown, Inc. announces 2024 second-quarter earnings release and conference call dates

DAYTONA BEACH, Fla., July 01, 2024 (GLOBE NEWSWIRE) — Brown & Brown, Inc. (NYSE: BRO) announces it will release its 2024 second-quarter earnings on Monday, July 22, 2024, after the close of the market. On Tuesday, July 23, 2024, J. Powell Brown, Brown & Brown’s president and chief executive officer, and R. Andrew Watts, Brown & Brown’s executive vice president and chief financial officer, will host an investor update conference call concerning Brown & Brown’s second-quarter 2024 financial results. You are invited to listen to the call, which will be broadcast live on Brown & Brown’s website at 8:00 a.m. EDT. Simply log on to www.bbinsurance.com and click on “Investor Relations” and then “Calendar of Events.” If you are unable to listen during the live webcast, audio from...

Continue reading

Hut 8 Announces Closing of $150 Million Investment from Coatue

Miami, July 01, 2024 (GLOBE NEWSWIRE) — Hut 8 Corp. (Nasdaq | TSX: HUT) (“Hut 8” or the “Company”), a leading, vertically integrated operator of large-scale energy infrastructure and one of North America’s largest Bitcoin miners, is pleased to announce it has closed its previously announced $150 million convertible note investment from a fund managed by Coatue Management, L.L.C. (“Coatue”). This press release shall not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. The Company intends to rely on an exemption set forth in Section 602.1 of the TSX Company...

Continue reading

SpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN

STAMFORD, Conn., July 01, 2024 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today that the Company has completed the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for mirdametinib, an investigational MEK inhibitor, for the treatment of pediatric and adult patients with neurofibromatosis type 1- associated plexiform neurofibromas (NF1-PN). “We are pleased to be one step closer towards our goal of bringing mirdametinib to patients with NF1-PN in the U.S. and believe that our ReNeu data support the potential for mirdametinib to be a differentiated and best-in-class therapy for both children and adults living with this devastating disease,” said Saqib Islam, Chief Executive...

Continue reading

Hut 8 Announces Closing of $150 Million Investment from Coatue

MIAMI, July 01, 2024 (GLOBE NEWSWIRE) — Hut 8 Corp. (Nasdaq | TSX: HUT) (“Hut 8” or the “Company”), a leading, vertically integrated operator of large-scale energy infrastructure and one of North America’s largest Bitcoin miners, is pleased to announce it has closed its previously announced $150 million convertible note investment from a fund managed by Coatue Management, L.L.C. (“Coatue”). This press release shall not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. The Company intends to rely on an exemption set forth in Section 602.1 of the TSX Company...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.